A Study of Guselkumab in Participants With Active Psoriatic Arthritis
Clinical trial NCT04882098 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04882098
- Sponsor
- Janssen Research & Development, LLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-17
- Primary completion
- 2024-12-30
- Enrollment
- 1054
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.